Skip to main content
GEATF logo

Radiko Holdings Corp (GEATF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.00001 $0.00 (0.00%)
Vol: 7.9K| 52-wk range: $0.000001 – $0.00001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Radiko Holdings Corp (GEATF) trades at $0.00001. Radiko Holdings Corp. operates in the cannabis industry, focusing on the manufacturing and distribution of cannabis-infused products. Sector: Healthcare.

Price as of · Last analyzed: Mar 16, 2026
Radiko Holdings Corp. operates in the cannabis industry, focusing on the manufacturing and distribution of cannabis-infused products. The company's diverse brand portfolio targets various consumer segments within the cannabis market, both in the United States and internationally.

Analyst Coverage for GEATF: GEATF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the GEATF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Radiko Holdings Corp (GEATF) Healthcare & Pipeline Overview

CEOScott Michael Reeves
Employees22
HeadquartersDes Moines, US
IPO Year2017

Radiko Holdings Corp. is a cannabis-focused company that manufactures and distributes a range of cannabis-infused products under brands like La Vida Verde, Skunk Feather, the Blank Brand, and Baseline. Operating in the U.S. and internationally, Radiko caters to diverse consumer segments within the evolving cannabis market, facing challenges typical of OTC-listed companies.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for GEATF?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Radiko Holdings Corp. presents a speculative investment opportunity within the cannabis sector, characterized by high growth potential but also significant risks. The company's diverse brand portfolio and focus on cannabis-infused products position it to capitalize on the expanding cannabis market. However, negative profit and gross margins of -205.5% and -31.0%, respectively, raise concerns about its financial sustainability. As an OTC-listed company, Radiko faces additional scrutiny regarding liquidity and disclosure. The company's beta of -2.86 suggests a negative correlation with the market, which could be seen as both a risk and an opportunity. Investors should carefully weigh the potential for growth in the cannabis market against the financial challenges and risks associated with Radiko's operations and OTC listing. The absence of dividends further impacts the investment profile, making it reliant on capital appreciation.

Based on FMP financials and quantitative analysis

GEATF Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $0.00B indicates a micro-cap company with high growth potential and associated risks.

  • Negative P/E ratio of -0.00 reflects the company's current lack of profitability.
  • Profit margin of -205.5% highlights significant operational challenges and the need for improved efficiency.
  • Gross margin of -31.0% indicates that the cost of goods sold exceeds revenue, requiring strategic adjustments.
  • Beta of -2.86 suggests a negative correlation with the market, potentially offering diversification benefits.

Who Are GEATF's Competitors?

GEATF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
MEDS TRxADE HEALTH, Inc. $3.68 -9.36% $9.65M —
MSLE Satellos Bioscience Inc. Common Stock $8.50 -0.12% $11.0M —
NEUP Neuphoria Therapeutics Inc. $3.47 -1.14% $18.8M —
AIXC AIxCrypto Holdings, Inc. $1.01 -39.16% $20.4M —
RNTX Rein Therapeutics, Inc. $0.80 -6.03% $22.4M —
KYNB Kyntra Bio, Inc. $6.31 -2.92% $25.5M —
YI 111, Inc. $3.22 -2.57% $28.1M —
PETS PetMed Express, Inc. $1.36 -0.73% $29.1M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are GEATF's Key Strengths?

Diverse brand portfolio.

  • Established distribution network.
  • Focus on cannabis-infused products.
  • Operations in the United States and internationally.

What Are GEATF's Weaknesses?

Negative profit and gross margins.

  • Reliance on OTC market listing.
  • Limited financial resources.
  • Small market capitalization.

What Are the Key Risks for GEATF?

Financial-distress signal — its Altman Z-Score of -9.01 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Regulatory uncertainty and changing cannabis laws.
  • Intense competition from other cannabis companies.
  • Fluctuations in cannabis prices and supply chain disruptions.
  • Limited access to capital and financing challenges.
  • Risks associated with OTC market listing, including limited disclosure and liquidity.

What Are GEATF's Competitive Advantages?

  • Brand portfolio targeting diverse consumer segments.
  • Established distribution network.
  • Proprietary formulations and extraction methods.
  • First-mover advantage in certain markets.

What Does GEATF Do?

Radiko Holdings Corp., formerly known as International Cannabrands Inc., rebranded in July 2020 to reflect its evolving focus on the cannabis industry. Headquartered in Des Moines, Washington, the company operates both in the United States and internationally. Radiko manufactures and distributes a diverse range of cannabis-infused products, targeting various consumer preferences and market segments. Its product portfolio includes edibles, tinctures, wholesale flower, packaged flower, pre-rolls, concentrates, chocolates, gummies, capsules, and supplements. These products are marketed under several distinct brands, each designed to appeal to a specific niche within the cannabis market. La Vida Verde offers a range of cannabis-infused edibles and tinctures, while Skunk Feather focuses on wholesale and packaged flower, pre-rolls, and concentrates. The Blank Brand provides cannabis-infused chocolates, edible cannabis consumables, gummies, and capsules. Baseline offers supplements. Radiko's strategic approach involves developing and marketing a variety of cannabis products to capture different segments of the market. Radiko faces competition from other cannabis companies, both large and small, as well as regulatory hurdles common to the industry.

What Products and Services Does GEATF Offer?

  • Manufactures cannabis-infused edibles and tinctures under the La Vida Verde brand.
  • Distributes wholesale flower, packaged flower, pre-rolls, and concentrates under the Skunk Feather brand.
  • Produces cannabis-infused chocolates, gummies, and capsules under the Blank Brand.
  • Offers supplements under the Baseline brand.
  • Focuses on cannabis industries in the United States and internationally.
  • Develops and markets a variety of cannabis products to capture different segments of the market.

How Does GEATF Make Money?

  • Manufacturing and distribution of cannabis-infused products.
  • Sales of products through wholesale and retail channels.
  • Brand licensing and partnerships.
  • Development of new cannabis products and formulations.

What Industry Does GEATF Operate In?

Radiko Holdings Corp. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing acceptance of cannabis for both medical and recreational use, driving demand for various cannabis-infused products. However, the industry also faces challenges such as regulatory uncertainty, intense competition, and varying state and federal laws. Radiko competes with other cannabis companies, including CSTF, DKSC, ERBB, FITX, and FTEG, as well as larger players in the consumer packaged goods and pharmaceutical sectors. The company's success depends on its ability to navigate these challenges, differentiate its products, and establish a strong brand presence in a competitive market.

Who Are GEATF's Key Customers?

  • Consumers of cannabis-infused edibles and tinctures.
  • Wholesalers and retailers of cannabis products.
  • Medical cannabis patients.
  • Recreational cannabis users.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Radiko Holdings Corp operates in the Healthcare sector. It is headquartered in Des Moines, US. GEATF has traded publicly since 2017.

F-Score 3/9

Financial Health

Radiko Holdings Corp's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -9.01 places it in the distress zone, a signal of elevated financial risk.

GEATF Financials

GEATF Latest News

GEATF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GEATF.

Price Targets

Wall Street price target analysis for GEATF.

GEATF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GEATF; grades run from A+ (80-100) to F (below 30).

Leadership: Scott Michael Reeves

CEO

Information on Scott Michael Reeves's background is limited. Details regarding his career history, education, and previous roles are not specified. Further research would be required to provide a comprehensive overview of his professional background and credentials.

Track Record: Due to the limited information available, it is not possible to assess Scott Michael Reeves's track record. Key achievements, strategic decisions, and company milestones under his leadership cannot be determined without additional data. Further research is needed to evaluate his performance as CEO of Radiko Holdings Corp.

GEATF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks due to less stringent regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier is often populated by shell companies, companies in distress, or those with limited operating history. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.

  • OTC Tier: OTC Other
Liquidity: As an OTC-listed company, Radiko Holdings Corp. likely experiences lower trading volumes and wider bid-ask spreads compared to companies listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at a desired price. The limited liquidity can also increase price volatility, making the stock more susceptible to large price swings. Investors should be aware of these liquidity challenges and factor them into their investment decisions.
OTC Risk Factors:
  • Limited financial disclosure.
  • Lower trading volume and liquidity.
  • Wider bid-ask spreads.
  • Greater price volatility.
  • Potential for fraud or manipulation.
Due Diligence Checklist:
  • Verify the company's registration and legal standing.
  • Obtain and review any available financial statements.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their experience.
  • Understand the risks associated with the cannabis industry.
  • Consider the liquidity challenges of OTC stocks.
  • Consult with a financial advisor.
Legitimacy Signals:
  • Operations in the United States and internationally.
  • Diverse brand portfolio.
  • Focus on cannabis-infused products.
  • Established distribution network.

What Investors Ask About Radiko Holdings Corp (GEATF) — Healthcare

What do analysts say about GEATF stock?

As of March 16, 2026, there is no available analyst coverage for Radiko Holdings Corp. (GEATF). Given its OTC listing and small market capitalization, the company may not be widely followed by analysts. Investors should conduct their own independent research and due diligence before investing in GEATF.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on CEO's background and track record.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis